Guardant Health (GH) Tops Q2 EPS by 26c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Guardant Health (GH) PT Raised to $40 at Jefferies
August 8, 2024 6:47 AM EDTJefferies analyst Tycho Peterson raised the price target on Guardant Health (NASDAQ: GH) to $40.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "After months of scrutiny on Shield, GH's core therapy selection business stole back some of the spotlight, as G360... More
